57/100BCSX stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for CSX is 52.47, 1.1% above the current price of 51.92. Their targets range from 32.00 to 60.00.
Of the 16 firms that rated CSX in the past 12 months, 10 rate it buy or strong buy, 5 hold and 1 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 32.00 to 60.00, with an average of 52.47.
| Buy | 10 | |
| Hold | 5 | |
| Sell | 1 |
12-month price target
| Highest target | 60.00 |
| Average target | 52.47 |
| Lowest target | 32.00 |
| Current price | 51.92 |
CSX price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their CSX price target and rating?
How analysts rate CSX, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
10 of 16 firms rate it buy now, against 15 of 21 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
CSX analyst upgrades, downgrades and price targets
The latest rating change came on 14 July 2026, when Susquehanna upgraded CSX from Neutral to Positive. Its price target is 58.00, from 50.00. The most recent new target came from Evercore ISI on 23 October 2026: 53.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 23 Oct 2026 | Evercore ISI Jonathan Chappell | — | 51.00 → 53.00 | +3.9% | 51.67 |
| 23 Oct 2026 | Raymond James Patrick Tyler Brown | — | 53.00 → 55.00 | +3.8% | 51.67 |
| 22 Oct 2026 | UBS | Reiterated · Buy | 60.00 → 54.00 | -10.0% | 51.49 |
| 22 Oct 2026 | Bernstein David Vernon | — | 36.00 → 49.00 | +36.1% | 51.47 |
| 22 Oct 2026 | UBS | — | 60.00 | — | 48.40 |
| 15 Oct 2026 | Raymond James Patrick Tyler Brown | — | 56.00 → 53.00 | -5.4% | 48.56 |
| 24 Sept 2026 | RBC Capital | — | 54.00 → 53.00 | -1.9% | 47.20 |
| 31 Jul 2026 | Argus Research | — | 56.00 | — | 50.15 |
| 24 Jul 2026 | Deutsche Bank | — | 59.00 | — | 53.20 |
| 23 Jul 2026 | RBC Capital Walter Spracklin | Reiterated · Outperform | 51.00 → 54.00 | +5.9% | 52.68 |
| 23 Jul 2026 | Stifel Nicolaus | — | 54.00 | — | 52.68 |
| 23 Jul 2026 | BMO Capital | Reiterated · Market Perform | 45.00 → 52.00 | +15.6% | 52.11 |
| 23 Jul 2026 | Evercore ISI | Reiterated · In Line | 47.00 → 51.00 | +8.5% | 52.43 |
| 23 Jul 2026 | Barclays | Reiterated · Overweight | 55.00 → 60.00 | +9.1% | 49.93 |
| 14 Jul 2026 | Susquehanna | Upgraded · Neutral → Positive | 50.00 → 58.00 | +16.0% | 49.64 |
| 13 Jul 2026 | Raymond James | — | 45.00 → 56.00 | +24.4% | 49.80 |
| 10 Jul 2026 | Truist Financial | — | 46.00 | — | 49.57 |
| 7 Jul 2026 | Robert W. Baird Daniel Moore | — | 47.00 → 53.00 | +12.8% | 48.81 |
| 6 Jul 2026 | Morgan Stanley | Reiterated · Underweight | 30.00 → 32.00 | +6.7% | 49.12 |
| 25 Jun 2026 | Barclays Brandon Oglenski | Reiterated · Overweight | 47.00 → 55.00 | +17.0% | 46.06 |
| 25 Jun 2026 | Evercore ISI | Reiterated · In Line | 46.00 → 47.00 | +2.2% | 46.06 |
| 24 Jun 2026 | RBC Capital | — | 47.00 → 51.00 | +8.5% | 46.69 |
| 17 Jun 2026 | Wells Fargo | — | 40.00 → 53.00 | +32.5% | 46.90 |
| 5 Jun 2026 | Susquehanna | — | 39.00 → 50.00 | +28.2% | 46.99 |
| 11 May 2026 | Evercore ISI | — | 40.00 → 46.00 | +15.0% | 44.85 |
| 24 Apr 2026 | Robert W. Baird | — | 40.00 → 47.00 | +17.5% | 46.18 |
| 23 Apr 2026 | Wolfe Research | — | 50.00 | — | 46.44 |
| 23 Apr 2026 | RBC Capital Walter Spracklin | Reiterated · Outperform | 43.00 → 47.00 | +9.3% | 45.99 |
| 23 Apr 2026 | BMO Capital | Reiterated · Market Perform | 45.00 | — | 43.18 |
| 23 Apr 2026 | New Street | — | 49.00 | — | 43.18 |
| 23 Apr 2026 | Barclays | Reiterated · Overweight | 47.00 | — | 43.18 |
| 23 Apr 2026 | Goldman Sachs | Reiterated · Neutral | 41.00 | — | 43.18 |
| 23 Apr 2026 | Vertical Research | — | 44.00 | — | 43.18 |
| 23 Apr 2026 | Morgan Stanley | Downgraded · Equal Weight → Underweight | — | — | — |
| 15 Apr 2026 | Raymond James | — | 45.00 | — | 42.51 |
| 7 Apr 2026 | Citigroup | Downgraded · Buy → Neutral | — | — | — |
| 26 Mar 2026 | RBC Capital | — | 40.00 → 43.00 | +7.5% | 39.55 |
| 19 Mar 2026 | Evercore ISI Group | Downgraded · Outperform → In Line | — | — | — |
| 23 Jan 2026 | Susquehanna | — | 34.00 → 39.00 | +14.7% | 37.34 |
| 23 Jan 2026 | Evercore ISI | Reiterated · Outperform | 39.00 → 40.00 | +2.6% | 37.36 |
| 23 Jan 2026 | Bernstein David Vernon | Reiterated · Market Perform | 36.00 | — | 35.78 |
| 18 Dec 2025 | RBC Capital Walter Spracklin | — | 39.00 → 40.00 | +2.6% | 36.63 |
| 8 Dec 2025 | Morgan Stanley | Reiterated · Equal Weight | 30.00 | — | 36.30 |
CSX EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect CSX's EPS to grow 18.7% a year until 2028. Over the last 5 years it grew 5.1% a year, and over the last 3 years it fell 7.6%.
Analysts expect CSX's revenue to grow 6.2% a year until 2028. Over the last 5 years it grew 5.9% a year, and over the last 3 years it fell 1.7%.
Revenue
EPS
Does CSX beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 4.9% off the result, either way, and their revenue estimate 2.8%, over the last 12 quarters.
- EPS beats
- 78 / 135
- Revenue beats
- 75 / 120
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +1.5%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 21 Oct 2026 | 0.53 | 0.57 | +7.3% | 3.96B | 4.02B | +1.5% |
| Q2 FY2026 | 22 Jul 2026 | 0.52 | 0.54 | +4.2% | 3.89B | 3.94B | +1.0% |
| Q1 FY2026 | 22 Apr 2026 | 0.39 | 0.43 | +10.5% | 3.49B | 3.48B | -0.2% |
| Q4 FY2025 | 22 Jan 2026 | 0.41 | 0.39 | -5.1% | 3.54B | 3.51B | -0.9% |
| Q3 FY2025 | 16 Oct 2025 | 0.42 | 0.44 | +3.7% | 3.57B | 4.46B | +24.9% |
| Q2 FY2025 | 23 Jul 2025 | 0.42 | 0.44 | +5.8% | 3.58B | 3.57B | -0.1% |
| Q1 FY2025 | 16 Apr 2025 | 0.37 | 0.34 | -6.8% | 3.45B | 3.42B | -0.8% |
| Q4 FY2024 | 23 Jan 2025 | 0.44 | 0.42 | -4.5% | 3.56B | 3.54B | -0.5% |
| Q3 FY2024 | 16 Oct 2024 | 0.48 | 0.46 | -4.2% | 3.68B | 3.62B | -1.5% |
| Q2 FY2024 | 5 Aug 2024 | 0.48 | 0.49 | +2.1% | 3.70B | 3.70B | +0.1% |
| Q1 FY2024 | 17 Apr 2024 | 0.45 | 0.46 | +2.2% | 3.67B | 3.68B | +0.4% |
| Q4 FY2023 | 24 Jan 2024 | 0.44 | 0.45 | +2.3% | 3.63B | 3.68B | +1.5% |
CSX stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If CSX's earnings grow at the 17.0% a year analysts expect to FY2028, then 15.0% a year, it would earn about 3.41 a share in FY2030. At the P/E it has traded at over the last five years (15.9 to 26.9) that is 54.12 to 91.63 a share, or 71.35 at its average P/E of 20.9. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 2.06 | 32.72 | 43.14 | 55.40 |
| FY2027 | 2.35 | 37.31 | 49.19 | 63.17 |
| FY2028 | 2.58 | 40.92 | 53.95 | 69.29 |
| FY2029 (extrapolated) | 2.96 | 47.06 | 62.05 | 79.68 |
| FY2030 (extrapolated) | 3.41 | 54.12 | 71.35 | 91.63 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 15.0% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (15.9, 20.9, 26.9).
Is CSX stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
CSX's P/E of 26.9 is near the top of its 5-year range (14.7 to 31.2, median 19.6). Analysts expect faster growth than in recent years, which can explain part of the high P/E. Buyers pay less for each point of growth than usual: a PEG of 1.4 on expected growth against 3.8 on its median P/E and past five years' growth. At its usual P/E (19.6 × EPS of 1.93), CSX's fair value is 37.88; the price, 51.92, is 37.0% above it. Its forward P/E, on the consensus for FY2026, is 25.2.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (14.7 and 31.2). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 26.90
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 19.63
- Five-year P/E range
- 14.7 – 31.2
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 25.21
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 1.59
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +1.1%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 64.525 | 127.9762Price 64.53185 | +98.3% | |
| 28.410 | 56.3234Price 28.4196 | +98.2% | |
| 153.725 | 297.58169Price 153.73471 | +93.6% | |
| 243.002 | 464.71205Price 243.00627 | +91.2% | |
| 160.085 | 305.52160Price 160.09396 | +90.8% | |
| 37.565 | 71.4258Price 37.57193 | +90.1% | |
| 160.240 | 300.28225Price 160.24375 | +87.4% |
Furthest below the fair value on each stock's page, updated every day.